| scholarly article | Q13442814 |
| P50 | author | Alexander A. Khromykh | Q37368917 |
| P2093 | author name string | Roy A Hall | |
| Wen Jun Liu | |||
| Mario Lobigs | |||
| David C Clark | |||
| Xiang Ju Wang | |||
| P2860 | cites work | Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression | Q24522443 |
| Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection | Q24562957 | ||
| Inhibition of interferon signaling by dengue virus | Q24630622 | ||
| Differential virulence of West Nile strains for American crows | Q24817166 | ||
| Flavivirus Activates Phosphatidylinositol 3-Kinase Signaling To Block Caspase-Dependent Apoptotic Cell Death at the Early Stage of Virus Infection | Q27469840 | ||
| Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication | Q27470019 | ||
| Inhibition of Transcription and Translation in Sindbis Virus-Infected Cells | Q27470247 | ||
| Infectious cDNA clone of the epidemic west nile virus from New York City | Q27472878 | ||
| Molecular and Functional Analyses of Kunjin Virus Infectious cDNA Clones Demonstrate the Essential Roles for NS2A in Virus Assembly and for a Nonconservative Residue in NS3 in RNA Replication | Q27477562 | ||
| Subgenomic replicons of the flavivirus Kunjin: construction and applications | Q27480783 | ||
| DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus | Q27480946 | ||
| Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells | Q27485958 | ||
| Viruses and interferon: a fight for supremacy | Q28220397 | ||
| A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice | Q28609778 | ||
| Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures | Q29618978 | ||
| Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins | Q29620712 | ||
| Viruses and interferons | Q29620788 | ||
| West Nile Virus Transmission in Resident Birds, Dominican Republic | Q33194871 | ||
| West Nile virus inhibits the signal transduction pathway of alpha interferon | Q33718537 | ||
| Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs | Q33843120 | ||
| Attenuation of equine influenza viruses through truncations of the NS1 protein | Q33843410 | ||
| Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection | Q34355773 | ||
| Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling | Q34361655 | ||
| The ecology and epidemiology of Kunjin virus | Q34705765 | ||
| The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway | Q35122610 | ||
| Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors | Q35844406 | ||
| Inverse interference: how viruses fight the interferon system | Q36020589 | ||
| Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses--and viruses counteract IFN action | Q36080993 | ||
| Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses | Q36096753 | ||
| Viruses know it all: new insights into IFN networks | Q36142963 | ||
| Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical | Q36510607 | ||
| Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription | Q37596892 | ||
| Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. | Q39550411 | ||
| Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells | Q39752893 | ||
| Studies on avian infectious bronchitis virus (IBV). III. Interferon induction by and sensitivity to interferon of IBV. | Q40272135 | ||
| Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. | Q40623650 | ||
| Murray Valley encephalitis virus field strains from Australia and Papua New Guinea: studies on the sequence of the major envelope protein gene and virulence for mice | Q40785472 | ||
| Virus spread, tissue inflammation and antiviral response in brains of flavivirus susceptible and resistant mice acutely infected with Murray Valley encephalitis virus. | Q42983533 | ||
| Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. | Q42995762 | ||
| Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus | Q43049528 | ||
| Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice | Q45743909 | ||
| P433 | issue | 5 | |
| P921 | main subject | virus | Q808 |
| West Nile virus | Q158856 | ||
| virulence | Q1460232 | ||
| P304 | page(s) | 2396-404 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | A Single Amino Acid Substitution in the West Nile Virus Nonstructural Protein NS2A Disables Its Ability To Inhibit Alpha/Beta Interferon Induction and Attenuates Virus Virulence in Mice | |
| P478 | volume | 80 |
| Q38836534 | A Brief Review of West Nile Virus Biology |
| Q27480366 | A Combination of Naturally Occurring Mutations in North American West Nile Virus Nonstructural Protein Genes and in the 3' Untranslated Region Alters Virus Phenotype |
| Q22337381 | A Highly Structured, Nuclease-Resistant, Noncoding RNA Produced by Flaviviruses Is Required for Pathogenicity |
| Q42983982 | A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy |
| Q27321020 | A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations |
| Q35641199 | A Single Amino Acid Substitution in the NS2A Protein of Japanese Encephalitis Virus Affects Virus Propagation In Vitro but Not In Vivo |
| Q35488765 | A basic cluster in the N terminus of yellow fever virus NS2A contributes to infectious particle production |
| Q33602692 | A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice |
| Q27481037 | A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis |
| Q92289508 | A natural polymorphism in Zika virus NS2A protein responsible of virulence in mice |
| Q33708559 | Abrogation of TLR3 inhibition by discrete amino acid changes in the C-terminal half of the West Nile virus NS1 protein |
| Q62485332 | Advances in Zika Virus⁻Host Cell Interaction: Current Knowledge and Future Perspectives |
| Q57296688 | An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo |
| Q38866173 | An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection |
| Q39347222 | Antagonism of type I interferon by flaviviruses |
| Q90131024 | Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses |
| Q89790279 | Binding of Duck Tembusu virus nonstructural protein 2A to duSTING disrupts the induction of its signal transduction cascade to inhibit IFN-β induction |
| Q45325120 | Biological and phylogenetic characteristics of West African lineages of West Nile virus |
| Q36276476 | Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. |
| Q27480936 | Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms |
| Q36287746 | Cell-intrinsic innate immune control of West Nile virus infection |
| Q36736579 | Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication. |
| Q27485096 | Characterization of a small plaque variant of West Nile virus isolated in New York in 2000 |
| Q34046030 | Chikungunya virus arthritis in adult wild-type mice |
| Q35220195 | Clinical outcome and genetic differences within a monophyletic Dengue virus type 2 population |
| Q23302003 | Comparative genomic analysis of pre-epidemic and epidemic Zika virus strains for virological factors potentially associated with the rapidly expanding epidemic |
| Q35075777 | Comparison of the neuropathology induced by two West Nile virus strains |
| Q37734118 | Construction and characterisation of a complete reverse genetics system of dengue virus type 3. |
| Q40349415 | Construction of an infectious cDNA clone for Omsk hemorrhagic fever virus, and characterization of mutations in NS2A and NS5. |
| Q34788758 | Current trends in West Nile virus vaccine development |
| Q37547492 | Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response |
| Q35620170 | Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant |
| Q40225767 | Dengue virus subgenomic RNA induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway |
| Q40374575 | Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus |
| Q38864403 | Development of a human live attenuated West Nile infectious DNA vaccine: conceptual design of the vaccine candidate |
| Q61813519 | Differential Expression of Genes Related to Innate Immune Responses in Ex Vivo Spinal Cord and Cerebellar Slice Cultures Infected with West Nile Virus |
| Q27484990 | Differential Expression of Interferon (IFN) Regulatory Factors and IFN-Stimulated Genes at Early Times after West Nile Virus Infection of Mouse Embryo Fibroblasts |
| Q37376398 | Differential virulence and pathogenesis of West Nile viruses |
| Q27481032 | Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon Production |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q27485316 | Establishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1 |
| Q34428035 | Evidence for co-evolution of West Nile Virus and house sparrows in North America |
| Q39565102 | Evolution of attenuating mutations in dengue-2 strain S16803 PDK50 vaccine and comparison of growth kinetics with parent virus |
| Q66679082 | Evolutionary dynamics and molecular epidemiology of in New York State: 1999-2015 |
| Q39833503 | Fine-scale genetic variation and evolution of West Nile Virus in a transmission "hot spot" in suburban Chicago, USA. |
| Q27491325 | Flavitrack analysis of the structure and function of West Nile non-structural proteins |
| Q59360247 | Flaviviral RNA Structures and Their Role in Replication and Immunity |
| Q89793960 | Flavivirus induces and antagonizes antiviral RNA interference in both mammals and mosquitoes |
| Q90798978 | Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis |
| Q38289956 | Flavivirus reverse genetic systems, construction techniques and applications: a historical perspective |
| Q43047786 | Formation of membrane-defined compartments by tick-borne encephalitis virus contributes to the early delay in interferon signaling. |
| Q42990600 | Generating flavivirus vaccine candidates by modulating interferon sensitivity |
| Q63246157 | Genetic and biochemical characterizations of Zika virus NS2A protein |
| Q35876730 | Genetic characterization of West Nile virus lineage 2, Greece, 2010. |
| Q34496125 | Genetic determinants of differential oral infection phenotypes of West Nile and St. Louis encephalitis viruses in Culex spp. mosquitoes |
| Q37673163 | IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts |
| Q34460502 | IS-98-ST1 West Nile virus derived from an infectious cDNA clone retains neuroinvasiveness and neurovirulence properties of the original virus |
| Q38059915 | Immune evasion strategies of flaviviruses |
| Q36673924 | Immunopathology of flavivirus infections |
| Q36645530 | In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model |
| Q36978578 | Increased early RNA replication by chimeric West Nile virus W956IC leads to IPS-1-mediated activation of NF-κB and insufficient virus-mediated counteraction of the resulting canonical type I interferon signaling |
| Q39351015 | Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar |
| Q40198668 | Inhibition of multiple strains of Venezuelan equine encephalitis virus by a pool of four short interfering RNAs |
| Q28950689 | Inhibition of type I interferon induction and signalling by mosquito-borne flaviviruses |
| Q38993846 | Innate immune escape by Dengue and West Nile viruses |
| Q27489865 | Innate immune evasion by hepatitis C virus and West Nile virus |
| Q33347656 | Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42. |
| Q40407813 | Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine |
| Q38717199 | Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB. |
| Q26699999 | Limited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell Culture |
| Q37726746 | Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus |
| Q27025556 | Mechanism of West Nile virus neuroinvasion: a critical appraisal |
| Q27676369 | Membrane Topology and Function of Dengue Virus NS2A Protein |
| Q35154026 | Molecular evolution of West Nile virus in a northern temperate region: Connecticut, USA 1999-2008 |
| Q40062309 | Mutagenesis of Dengue Virus Protein NS2A Revealed a Novel Domain Responsible for Virus-Induced Cytopathic Effect and Interactions between NS2A and NS2B Transmembrane Segments |
| Q40154937 | Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo |
| Q27490848 | NS1' of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness |
| Q36559961 | Neurotropic arboviruses induce interferon regulatory factor 3-mediated neuronal responses that are cytoprotective, interferon independent, and inhibited by Western equine encephalitis virus capsid |
| Q47548030 | New Targets for Zika Virus Determined by Human-Viral Interactomic: A Bioinformatics Approach |
| Q56354615 | PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins |
| Q27473291 | PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in Neurons |
| Q27477543 | Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion |
| Q92985403 | Phylogenetic analysis of West Nile virus in Quebec, Canada, 2004-2016: Co-circulation of distinct variants harbouring conserved amino acid motifs in North America |
| Q37572667 | Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission |
| Q34466812 | Programmed ribosomal frameshift alters expression of west nile virus genes and facilitates virus replication in birds and mosquitoes |
| Q27489893 | Progress on the development of therapeutics against West Nile virus |
| Q27107485 | RNA structures required for production of subgenomic flavivirus RNA |
| Q35677531 | Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate |
| Q40041785 | Regulation of Apoptosis during Flavivirus Infection |
| Q37566687 | Replication cycle and molecular biology of the West Nile virus |
| Q60031631 | Research advancements in the neurological presentation of flaviviruses |
| Q27485896 | Role of Nonstructural Protein NS2A in Flavivirus Assembly |
| Q95644980 | Role of pattern recognition receptors and interferon-beta in protecting bat cell lines from encephalomyocarditis virus and Japanese encephalitis virus infection |
| Q21090517 | Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism |
| Q35640994 | Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion |
| Q38152910 | Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. |
| Q34218526 | Structural gene (prME) chimeras of St Louis encephalitis virus and West Nile virus exhibit altered in vitro cytopathic and growth phenotypes |
| Q57158255 | Subgenomic flaviviral RNAs: What do we know after the first decade of research |
| Q27468655 | TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A |
| Q36523926 | The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment |
| Q39046949 | The West Nile virus assembly process evades the conserved antiviral mechanism of the interferon-induced MxA protein |
| Q38726766 | The calmodulin antagonist W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride) inhibits DENV infection in Huh-7 cells. |
| Q39440343 | The generation of a reverse genetics system for Kyasanur Forest Disease Virus and the ability to antagonize the induction of the antiviral state in vitro |
| Q39575239 | The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response |
| Q35150808 | The relationship between the structure of the tick-borne encephalitis virus strains and their pathogenic properties. |
| Q31034150 | The role of interferon antagonist, non-structural proteins in the pathogenesis and emergence of arboviruses |
| Q22809893 | The role of viral persistence in flavivirus biology |
| Q90503191 | Tick-borne encephalitis virus NS4A ubiquitination antagonizes type I interferon-stimulated STAT1/2 signalling pathway |
| Q34055431 | Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles |
| Q37006727 | Toll-like receptor 7 suppresses virus replication in neurons but does not affect viral pathogenesis in a mouse model of Langat virus infection |
| Q27477616 | Translation of the Flavivirus Kunjin NS3 Gene in cis but Not Its RNA Sequence or Secondary Structure Is Essential for Efficient RNA Packaging |
| Q34991051 | Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly |
| Q27011587 | Understanding the dengue viruses and progress towards their control |
| Q37842337 | Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus |
| Q26999702 | Vaccines in development against West Nile virus |
| Q41048750 | Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses |
| Q38885624 | Viral and Synthetic RNA Vector Technologies and Applications |
| Q36926779 | Viral stress-inducible genes. |
| Q34949783 | Virulence determinants between New York 99 and Kunjin strains of West Nile virus |
| Q41935743 | Virulence determinants of West Nile virus: how can these be used for vaccine design? |
| Q27488737 | Virus and Host Determinants of West Nile Virus Pathogenesis |
| Q37634452 | Virus-induced transcriptional changes in the brain include the differential expression of genes associated with interferon, apoptosis, interleukin 17 receptor A, and glutamate signaling as well as flavivirus-specific upregulation of tRNA synthetases |
| Q27486783 | West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction |
| Q26513109 | West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms |
| Q27481490 | West Nile Virus-Induced Neuroinflammation: Glial Infection and Capsid Protein-Mediated Neurovirulence |
| Q26865618 | West Nile Virus: biology, transmission, and human infection |
| Q37006746 | West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response |
| Q34035068 | West Nile virus and its emergence in the United States of America |
| Q38074266 | West Nile virus infection and immunity |
| Q64988889 | West Nile virus infection and interferon alpha treatment alter the spectrum and the levels of coding and noncoding host RNAs secreted in extracellular vesicles. |
| Q35943585 | West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response |
| Q35826344 | West Nile virus population genetics and evolution |
| Q51714865 | West Nile virus. |
| Q37195527 | West Nile virus: A re-emerging pathogen revisited |
| Q37876095 | West Nile virus: the complex biology of an emerging pathogen |
| Q30227143 | West nile virus: characteristics of an african virus adapting to the third millennium world. |
| Q38158918 | Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions |
| Q44169814 | Zika virus: what we need to know? |
Search more.